EMILY KANE: Open Payments
NPI 1386855468 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,848 in 37 payments from 11 companies in 2025. Trend: 2023 $302 · 2024 $2,059 · 2025 $2,848
Honoraria: $1,750Food & beverage: $1,098
| Company | Payments | Amount |
|---|---|---|
| ALK-Abello, Inc | 2 | $1,750 |
| ARS Pharmaceuticals Operations, Inc. | 5 | $320 |
| GENZYME CORPORATION | 8 | $277 |
| Regeneron Healthcare Solutions, Inc. | 8 | $163 |
| GlaxoSmithKline, LLC. | 7 | $115 |
| PFIZER INC. | 1 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $48 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| ABBVIE INC. | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
Products named: Odactra, DUPIXENT, NEFFY, NUCALA, NURTEC ODT, TEZSPIRE, INSPIRE, UBRELVY.
Industry payments across VA — which companies pay providers there.
